Can Preoperative Ferric Carboxymaltose Reduce Postoperative Blood Transfusion in Bilateral Total Knee Arthroplasty
Not Applicable
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0004015
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 156
Inclusion Criteria
Patients who undertake bilateral staged Total Knee Arthroplasty, and havd iron deficiency anemia (Male 8<Hb<13, Female 7<Hb<13)
Exclusion Criteria
- First operation Preop Hb <8g/dL, thrombocytopenia
- C-reactive protein 1 or more (> 2xUNL)
- Systemic inflammatory diseases
- Use of iron supplements within 4 weeks
- Intravenous iron, or erythropoietin within 4 weeks
- Preoperative use of anticoagulant (warfarin, factor Xa inhibitor)
- Coagulopathy
- Chronic renal failure
- Patients with hypersensitivity to this drug or its components
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transfusion
- Secondary Outcome Measures
Name Time Method Hemoglobin level